Top first-in-class drug candidates of 2025: Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten await FDA approval

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Cholecalciferol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 19 USDMF, 15 CEP/COS, 2 JDMF, 2 EU WC, 3 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

715 FDF Dossiers, 6 FDA Orange Book, 412 Europe, 36 Canada, 4 South Africa, 257 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, TABLET;ORAL - EQ 70MG BASE;2,800 IU, TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 12 Rochem International Inc, 19 SPI Pharma, 18 DKSH, 2 Pharm-RX Chemical, 10 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 32 BASF, 1 Bioplus Life Sciences, 1 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 33 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 12 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 35 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

101 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 48 Thickeners and Stabilizers, 40 Taste Masking, 37 Solubilizers, 34 Direct Compression, 32 Controlled & Modified Release, 29 Granulation, 27 Topical, 27 Parenteral, 25 Film Formers & Plasticizers, 23 Disintegrants & Superdisintegrants, 20 Chewable & Orodispersible Aids, 18 Lubricants & Glidants, 18 Co-Processed Excipients, 16 Rheology Modifiers, 12 Emulsifying Agents, 9 Empty Capsules, 8 API Stability Enhancers, 6 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 24 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

376 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

78 APIs, 23 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 3 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
24/02/2025	DISHMAN NETHERLANDS B.V.	Netherlands	DISHMAN NETHERLANDS B.V. Veenendaal NL	R1-CEP 2007-347 - Rev 00	Cholecalciferol concentrate (oily form), 2 000 000 IU/g in arachis oil	2014-07-18	Valid	Chemical and TSE		575
24/02/2025	DISHMAN NETHERLANDS B.V.	Netherlands	DISHMAN NETHERLANDS B.V. Veenendaal NL	R1-CEP 2005-098 - Rev 03	Cholecalciferol	2012-02-07	Withdrawn by Holder	Chemical and TSE	2023-07-20	72

Cholecalciferol

Cholecalciferol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers

19 USDMF

15 CEP/COS

2 JDMF

2 EU WC

3 NDC API

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

715 FDF Dossiers

6 FDA Orange Book

412 Europe

36 Canada

4 South Africa

257 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

TABLET;ORAL - EQ 70MG BASE;2,800 IU

TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

2 EUROAPI

12 Rochem International Inc

19 SPI Pharma

18 DKSH

2 Pharm-RX Chemical

10 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

11 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

32 BASF

1 Bioplus Life Sciences

1 Clariant

11 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

2 Finar

11 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

33 Kerry

5 Kima Chemical

6 Lonza Capsugel

19 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

12 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

35 Roquette

16 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 The Dow Chemical Company

1 Ulanqab Kema New Material

1 Valens Pharmachem

3 Vasa Pharmachem

2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

101 Fillers, Diluents & Binders

57 Coating Systems & Additives